Colorectal cancer

Victor Moreno Aguado / Ramon Salazar Soler

PRINCIPAL INVESTIGATORS
  • Mercedes Martinez Villacampa
  • Cristina Santos Vivas
  • Gemma Soler González
  • Eric Jeffrey Duell
CLINICAL RESEARCHERS
  • Francisco Rodríguez Moranta
  • Ferran Losa Gaspà
  • Albert Sueiras Gil
  • Mireia Obon Santacana
  • Esther Kreisler Moreno
  • Jose Carlos Ruffinelli Rodríguez
  • Doménico Nicola Fraccalvieri
POSTDOCTORAL RESEARCHERS
  • Marisa Martínez Muñoz
  • Alba Magallon Baro
  • Elies Ramon Gurrea
  • Gemma Ibañez Sanz
  • Nuria Moragas Garcia
  • Miguel Socolovsky Visiedo
  • Francisco David Moron Duran
  • Claudia Monica Aura Gonzalez
  • David Bars Cortina
    Ditsuhi Iskandaryan
PREDOCTORAL RESEARCHERS
  • Blanca Rius Sansalvador
  • Lois Riobo Mayo
SCIENTIFIC SUPPORT
  • Eduardo Delgado De La Iglesia
  • Anna Diez Villanueva
  • Susana Lopez Ruiz
  • Catalina Medici
  • Elisabet Guino Domenech
  • Ferran Moratalla Navarro
  • Carmen Rosa Atencia Rojas
MANAGEMENT SUPPORT
  • Thiago Carnaval
  • Mario Amigo Garcia
  • Jordi Vea Barbany
  • Adelaida Piera Sancerni
  • Silvia Murcia Muñoz
  • Olga Lopez Ciercoles
  • Paula Ximena Fernandez Calotti
  • Camille Martine Marie Frey
  • Catalina Isabel Cofre Muñoz
Cancer
Oncobell

Scientific production

74

PAPERS

Average IF: 8,825

22

LED PAPERS

Average IF: 4,005

16 PUBLICATIONS IN FIRST DECILE

43 PUBLICATIONS IN FIRST QUARTILE

58 PUBLICATIONS IN OPEN ACCESS

Selected publications:

  • Cortellini,A;Tabernero,J;Mukherjee,U;Salazar,R;Sureda,A;Maluquer,C;Ferrante,D et al, SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry, Lancet Oncol., 2023;24(4):335-346, doi:10.1016/S1470-2045(23)00056-6
  • Tagliamento,M;Gennari,A;Lambertini,M;Salazar,R;Harbeck,N;Del Mastro,L;Aguilar Company,J et al, Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer, J. Clin. Oncol., 2023;41(15):2800-2814 doi:10.1200/JCO.22.01667
  • Van Cutsem,E;Taieb,J;Yaeger,R;Yoshino,T;Grothey,A;Maiello,E;Elez,E et al, ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAF(V600E)-Mutant Metastatic Colorectal Cancer., J. Clin. Oncol., 2023;41(14):2628-2637, doi:10.1200/JCO.22.01693
  • Fernandez Rozadilla,C;Timofeeva,M;Chen,Z;Law,P;Thomas,M;Schmit,S;Díez Obrero,V et al, Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries., Nature Genet., 2023;55(1):89-99, doi:10.1038/s41588-022-01222-9
  • Mahmood,K;Thomas,M;Qu,C;Gecco Ccfr,C;Hsu,L;Buchanan,DD;Peters,U, Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes., Gastroenterology, 2023;165(4):doi:10.1053/j.gastro.2023.06.032

Research highlights

PROJECTS

2 Granted competitive projects
24 Ongoing competitive projects

11 Started clinical trials
39 Ongoing clinical trials

PUBLISHED WORKS

3 Clinical guidelines

NETWORKS

CIBERESP
ECPC
SGR GRC
PERSIST
ML4 Microbiome
GECCO
UNCAN

 

Selected projects

  • MCI21055. Federación de datos de salud: identificación inteligente de factores compartidos entre cáncer y enfermedades cardiovasculares para la mejorar prevención a lo largo de la vida (CC-Shared). Ministerio de Ciencia e Innovación. Budget: 524.400€. 2022-2024. PI: MORENO AGUADO, VICTOR RAUL.
  • 18PSJ019. Genetic and metabolomics screening towards the precision medicine in cancer prevention (Genrisk). Asociación Española Contra el Cáncer (AECC). Budget: 500.000€. 2018-2024. PI: MORENO AGUADO, VICTOR RAUL.
  • ERA21001. IMAGene: Epigenomic and machine learning models to predict pancreatic cancer: development of a new algorithm to integrate clinical, omics, DNA methylation biomarkers and environmental data for early detection of pancreatic cancer in high-risk individuals. Instituto de Salud Carlos III (ISCIII)/Asociación Española Contra el Cáncer (AECC). Budget: 304.687,96€. 2022-2025. PI: MORENO AGUADO, VICTOR RAUL.
  • ERA21004. TANGERINE: Artificial-intelligence-based end-to-end prediction of cancer immunotherapy response. Instituto de Salud Carlos III (ISCIII) / Asociación Española Contra el Cáncer (AECC). Budget: 296.341€. 2022-2025. PI: MORENO AGUADO, VICTOR RAUL.
  • 20FIS019. Refining the consensus molecular subtypes classification: prognostic and therapeutic implications in stage II colon cancer.. Instituto de Salud Carlos III (ISCIII). Budget: 159.720€. 2020-2024. PI: Salazar Soler, Ramón.